Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis - Wikidata - awgldk - TriplyDB

Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis

Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis

http://www.wikidata.org/entity/Q24633862

about

Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8 Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue Solution Structure of CXCL5 — A Novel Chemokine and Adipokine Implicated in Inflammation and Obesity The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium Comparison of CXC chemokines ENA-78 and interleukin-8 expression in Helicobacter pylori-associated gastritis.Chemokines and chemokine receptors in arthritis.Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium.Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients.CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium.Chemokines in joint disease: the key to inflammation?Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.CXCL5 signaling is a shared pathway of neuroinflammation and blood-brain barrier injury contributing to white matter injury in the immature brain.The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.CXCL5 stimulation of RANK ligand expression in Paget's disease of bone.IL-1α modulates neutrophil recruitment in chronic inflammation induced by hydrocarbon oil Synovial cellular and molecular markers in rheumatoid arthritis.Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis.Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis.Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.Signals and receptors involved in recruitment of inflammatory cells.Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment.Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease.T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis.

P2860

Q24793032-0E013CA5-85C3-4339-B187-D4DEB5C0374A Q24793680-811A6092-24AD-4F21-B3C2-DF572EA7916B Q24807279-77F6B244-7786-4F88-9CF1-667C17907ECA Q27682811-7F327B99-CF91-4514-BE61-A7FC7C012F54 Q28485981-6D4E0581-0EEF-404E-974C-08CC577ACED6 Q30427989-DC228D01-BA63-482E-B219-8FD0A99F39DB Q33646334-54A3AC54-3273-4ADF-AF56-F40F19584418 Q33652016-F6B3BAFA-5253-472B-84F3-515627D0CB01 Q34005492-97E0E1C5-7F39-4DB3-955B-29758A74A8A7 Q34051768-A9BB85A2-EDAE-414E-97E1-791802930D08 Q34134989-1504A51F-08BF-41B3-AF2C-7675A9717613 Q34144597-B36F2EAD-4A02-4E3E-95E3-CA45031DC414 Q34290822-45E74EBB-FD8C-4F44-B04F-4DFA763B046D Q34612497-6D692293-91EC-4914-A3FE-892C78706F2C Q34652416-067EB3E4-60B7-4B34-A53B-9EC9465FA699 Q34802798-48CE4A9C-DFAC-4EF3-9FFE-5CF0AFD1D586 Q34945471-7DB8FAA8-021D-48DB-AE3B-02185193FDA3 Q35471875-4FD6074A-81B7-4B5F-B69E-F8CFFDF4B38B Q35553416-77E99122-CACD-41B8-AAA3-3F98AC71D8AA Q35555525-B38B3CF8-5DC6-443F-B9EE-E6044DA23952 Q35605604-F1F9E2B0-4A8A-4432-BDF1-58C8DE6EA7BB Q35746847-CA66CAAA-3880-484A-8D00-437C709B8A4A Q35934127-2066089A-A033-4641-8858-725E140FD171 Q36439707-E614CC22-8EE8-4CED-BCE2-70AF9F7068D8 Q36992526-24597A69-BF8D-4150-8705-AD1549682E09 Q37229283-6C6D94D2-97F9-4B9E-BE6D-491F0E243B36 Q37316559-8E3C169F-5491-4161-8435-B66955C0C5AA Q38291506-05960C5C-935F-431C-B664-689BE04040FF Q38647749-8DB1360A-81D5-4B44-A2B4-5622168A4CFD Q39188901-1AA5D11A-873D-4DBD-B37E-DB93038187F6 Q39274974-A36001BD-0914-4F09-93C2-17991C407D2A Q39301702-79897D58-4C95-4E0E-93CA-DD6BDCD7EC9E Q39603082-5FF3DF5E-F7BD-4BB8-85D8-5AD1856CBC91 Q39885694-71696A20-87EC-4E6D-9B56-89BBA260BD45 Q40154356-02B2408E-59DC-4656-8686-AD673391E0E6 Q40522208-786E41E5-98D2-4E0F-BF8B-F965F77AD610 Q40563240-F3651CC8-A750-4CFD-A83C-01AD49BD9CB8 Q41661024-94A5DFE1-9ABC-4117-A4CB-0409EB962C81 Q41743838-F496E62C-CFEB-4982-AF76-635718476173 Q41815638-4B37176B-B054-4782-BDF9-EB049BA08F96

P2860

Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis

http://www.wikidata.org/entity/Q24633862

description

1994 nî lūn-bûn

@nan

1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@ast

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@en

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@nl

type

label

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@ast

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@en

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@nl

prefLabel

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@ast

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@en

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@nl

P1433

Q24633862-A62E8F74-ABEB-45EB-A4ED-77FA912D37C1

P1476

Q24633862-62281AA8-2D26-4910-9BE1-8173F8491287

P2093

Q24633862-15ADDB3D-6BED-4305-8F9F-64D3932DB89C

Q24633862-29D106AB-9624-4E7F-ADF4-A0252BC0AB64

Q24633862-3944C156-6FB0-4B61-98DC-B96B266337A1

Q24633862-61AD5196-AE1F-418C-8DF0-DEF3E72E39DF

Q24633862-758907F6-BC20-4BC3-AA6C-49FA80725939

Q24633862-795A9F22-5BEC-4A70-9B60-7A535FD136DE

Q24633862-AE5AAE66-F919-4088-B66E-DE8A7A688B9C

Q24633862-E379E34B-FB15-4E80-8153-287FA398F75E

Q24633862-E95827E0-6C38-430D-8CC7-68033C5BBF8C

P2860

Q24633862-325F7B97-38BD-4460-9742-AEF1544E63C5

Q24633862-36F997E0-7EB5-4B0C-B49E-249062848836

Q24633862-4679D211-C11A-4D05-A133-44CF93D223FC

Q24633862-54847F4B-DE40-48A1-9DC0-26A374CE36D7

Q24633862-738CBFDD-1C9D-4D50-94F4-1DCA6AF3A7C0

Q24633862-80BE442F-43C4-4410-960D-7B5E02BE56E9

Q24633862-8AB4FA05-9432-4C69-935C-836C80147158

Q24633862-A993822C-CACF-4667-A062-9F507EE95690

Q24633862-BEFC0B8B-F8E0-4350-B255-50F87664D405

Q24633862-CA7AD968-610F-4DFD-919E-F1ECFA83B007

P304

Q24633862-F35D5909-6077-4D64-9CF0-7BE92A11EDAF

P31

Q24633862-F2A32345-BBB5-4921-A39C-758C4EFB9E70

P356

Q24633862-C1B403CA-874A-4C6C-855F-284558495DFF

P407

Q24633862-1DA024B6-EA41-4F09-BCE1-43ECE53849ED

P433

Q24633862-AFE2CAF8-19A5-4F60-8A7D-C7B9B7D6B773

P478

Q24633862-696A427A-6272-4089-90B9-4362EEE2B001

P577

Q24633862-F3843533-9FCA-40DB-8775-639AE208FF05

P5875

Q24633862-6A07E94C-76A5-4EB9-BA40-0A294F74BA71

P698

Q24633862-4EA35CBA-93F7-4A58-AA5C-FAD1B9CBEC3A

P921

Q24633862-A95C00E1-C036-4E60-B4B0-AF3EA7DBD59E

P932

Q24633862-A2FA3F05-3288-4B6B-B33E-3D50B72CDA30

P356

P1433

Journal of Clinical Investigation

P1476

Epithelial neutrophil activati ...... e for neutrophils in arthritis

@en

P2093

A E Koch

http://www.w3.org/2001/XMLSchema#string

A Walz

http://www.w3.org/2001/XMLSchema#string

D D Mazarakis

http://www.w3.org/2001/XMLSchema#string

G K Haines

http://www.w3.org/2001/XMLSchema#string

L A Harlow

http://www.w3.org/2001/XMLSchema#string

M D Burdick

http://www.w3.org/2001/XMLSchema#string

R M Pope

http://www.w3.org/2001/XMLSchema#string

R M Strieter

http://www.w3.org/2001/XMLSchema#string

S L Kunkel

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Characterization of two high affinity human interleukin-8 receptors

Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.

Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association

Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.

Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1.

P304

1012-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117414

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1994-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15116591

http://www.w3.org/2001/XMLSchema#string

P698

8083342

http://www.w3.org/2001/XMLSchema#string

P921

P932

295150

http://www.w3.org/2001/XMLSchema#string